SMi Group reports: For anyone thinking about bringing digital health solutions to market, the workshop - Human factors for connected drug delivery systems, hosted by Cambr
SMi's 5th Annual Pre-Filled Syringes East Coast Conference and Exhibition (April 11 – 12, Boston, USA) will gather together 100+ CEOs and decision makers in the field of PFS, so entire years’ worth
The US FDA announced today that it has cleared two novel gene therapies for sickle cell disease: Vertex Pharmaceuticals' Casgevy and bluebird bio's Lyfgenia.
On 1st October, the roll-out of the National Contract Value Review (NCVR) process marked a pivotal moment in the trajectory of clinical research in the UK, introducing a standardised, natio